×

CPRD StudyPrimary Care PASS Study

Abstract 981: Passive Enhanced Safety Surveillance in children receiving Fluenz Tetra vaccination in England during the early 2016 influenza season

Fluenz® Tetra is a quadrivalent, live attenuated, intranasal, influenza vaccine recommended for use in children aged 2 to 17 years vaccinated as part of the seasonal influenza immunisation campaign in the UK.

CPRD StudyPrimary Care PASS Study

Abstract 868: Multi­Level Modelling (MLM) in Specialist Cohort Event Monitoring (SCEM) Studies

Prescribing guidelines (PG) influence treatment choice based on patient (pt) factors.

CPRD StudyPrimary Care PASS Study

Abstract 517: Utilisation and safety of deferasirox (Exjade®) in older adults: results from a post authorisation safety study (PASS)

A UK PASS examined the safety and use of deferasirox prescribed in primary care in England.